ENTITY
Zydus Lifesciences Ltd

Zydus Lifesciences Ltd (ZYDUSLIF IN)

99
Analysis
Health CareIndia
Cadila Healthcare Ltd. manufactures, and markets healthcare solutions ranging from formulations, active pharmaceutical ingredients, vaccines, diagnostics, health and dietetic foods, animal healthcare to cosmeceuticals. The Company's products are available in tablets, capsules, injections, liquids, dry syrups, powders, granules, and ointments.
more
Refresh
22 Mar 2024 20:05Broker

Zydus Lifesciences Ltd - Specialty Portfolio Growth to Drive Margins

Sharekhan's research report onZydus Lifesciences We reiterate a Buy on Zydus as domestic sales for February 2024 grew by 11.2% (IPM grew by 9%) and...

Logo
Sharekhan
379 Views
Share
12 Feb 2024 09:30

Zydus Lifesciences (ZYDUSLIF IN): Strong India Momentum; Q3 Net Profit Jumps 27%; Buyback Approved

​Zydus Lifesciences reported strong revenue growth and improved profitability in Q3FY24, leading to a 27% increase in net profit. The company also...

Logo
308 Views
Share
22 Aug 2023 22:18

Zydus Lifesciences (ZYDUSLIF IN): Strong Start of FY24 Riding on US Formulation Business

Quarterly revenue surpassed INR50B mark for 2nd consecutive quarter. Even upon a high base, US revenue increased 8% sequentially driven by new...

Logo
605 Views
Share
31 Jul 2023 06:30

NIFTY/NEXT50 Index Rebalance Preview: Loads of Changes if Proposed Methodology Is Implemented

There could be 5 changes with the current methodology or 11 with the proposed methodology. Turnover will be big in both cases. There is a lot of...

Logo
569 Views
Share
19 May 2023 22:37

Zydus Lifesciences (ZYDUSLIF IN): Strong Q4 Result Driven by US Business; Forward Growth to Moderate

Zydus Lifesciences recorded 32% revenue growth to INR50B in Q4FY23, driven by 58% growth in US formulation business. The company expects single...

Logo
435 Views
Share
x